We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Merck KGAA (MRK) Nil Par Value

Sell:€146.35 Buy:€147.05 Change: No change
Market closed |  Prices as at close on 18 April 2024 | Switch to live prices |
Sell:€146.35
Buy:€147.05
Change: No change
Market closed |  Prices as at close on 18 April 2024 | Switch to live prices |
Sell:€146.35
Buy:€147.05
Change: No change
Market closed |  Prices as at close on 18 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Electronics business enables digital living and provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.

Contact details

Address:
Frankfurter Str. 250
DARMSTADT
64293
Germany
Telephone:
+49 (6151) 720
Website:
https://www.emdgroup.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
MRK
ISIN:
DE0006599905
Market cap:
€64.00 billion
Shares in issue:
434.78 million
Sector:
Pharmaceuticals
Exchange:
Frankfurt Stock Exchange
Country:
Germany
Currency:
Euro
Indices:
n/a

Key personnel

  • Michael Kleinemeier
    Independent Chairman of the Supervisory Board
  • Belen Garijo
    Chairman of the Executive Board, Chief Executive Officer
  • Sascha Held
    Vice Chairman of the Supervisory Board
  • Helene Von Roeder
    Chief Financial Officer, Member of the Executive Board
  • Kai Beckmann
    Member of the Executive Board, Chief Executive Officer - Electronics
  • Peter Guenter
    Member of the Executive Board, Chief Executive Officer - Healthcare
  • Matthias Heinzel
    Member of the Executive Board, Chief Executive Officer - Life Science

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.